Lord's Mark
Lord's Mark Industries is an Indian diversified conglomerate pivoting into healthcare technology, building an integrated AI-powered renal care ecosystem (Renalyx machines, RenalOS AI platform, Aureoon managed services), HIV self-test diagnostics, US FDA-listed orthosurgical products, and an AI breast cancer detection wearable for hospitals and international export markets.
- Company typePrivate
- Founded1998
- HeadquartersMumbai, India
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Lord's Mark does
Lord's Mark Industries Ltd. is an Indian privately held diversified conglomerate headquartered in Mumbai, originally founded in 1998 with operations spanning the Paper, LED-Solar, and Diagnostics and Medtech sectors. The company has materially repositioned its growth agenda around healthcare technology since late 2025, with a stated focus on indigenous AI-powered medical devices and platforms under a 'Make in India' positioning. It operates a state-of-the-art manufacturing plant in Dadra & Nagar Haveli and has built an engineering and R&D footprint through the 85% acquisition of Bengaluru-based Renalyx Health Systems in November 2025.
The core healthcare offering is an integrated AI-powered renal care ecosystem composed of three interconnected components: the Lord's Renal Renalyx Machine (an indigenous AI-enabled hemodialysis system), the RenalOS AI clinical intelligence platform (providing real-time monitoring, predictive alerts, anomaly detection, and clinical decision support), and Aureoon (a Dialysis-as-a-Service managed operations model that allows hospitals to deploy fully managed centres with zero capital investment). The company's diagnostics portfolio includes the LordsMed HIV 1&2 Self Test (a Class D in-vitro diagnostic cleared by India's Central Licensing Authority, placing the company among only three Indian and nine global holders of this approval) and an AI-powered, radiation-free breast cancer detection wearable being co-developed with CMET. It also markets 153 US FDA-listed orthosurgical products manufactured at its Indian facility.
Lord's Mark generates revenue through a mix of hardware sales (dialysis equipment, diagnostic kits, orthosurgical products), managed services (per-session fees under the Aureoon model), and international exports. Its go-to-market combines enterprise field sales to hospitals for dialysis systems, direct-to-consumer distribution of HIV self-test kits, and export distribution into regulated markets (United States, European Union, Africa, Latin America, and the Middle East). The company relies primarily on public relations, earned media around regulatory milestones, and healthcare industry events rather than paid digital marketing, and it has signed flagship deployments such as the Shakti Super Speciality Hospital in Ahmedabad as the first commercial site for the integrated renal ecosystem.
Lord's Mark firmographics
Firmographics- Name
- Lord's Mark
- Legal name
- Lord's Mark Industries Ltd.
- Website
- https://lordsmark.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lord's Mark Industries is an Indian diversified conglomerate pivoting into healthcare technology, building an integrated AI-powered renal care ecosystem (Renalyx machines, RenalOS AI platform, Aureoon managed services), HIV self-test diagnostics, US FDA-listed orthosurgical products, and an AI breast cancer detection wearable for hospitals and international export markets.
- Ownership category
- akta.pro rank
Lord's Mark industry classification
Industry- Product category
- Medical Devices
- NAICS
- Kidney Dialysis Centers (621492), Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
Keywords
Where Lord's Mark is headquartered
LocationHeadquarters
- HQ city
- Mumbai
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Lord's Mark business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Dialysis Equipment and Consumables Sales: Sale of Lord's Renal Renalyx Machine and related dialysis consumables to hospitals and healthcare facilities
- Dialysis-as-a-Service Managed Operations: Managed dialysis centre operations where Lord's Mark provides complete infrastructure, AI systems, and operational support to hospital partners with zero capital required from them. Revenue generated through service fees per dialysis session
- Diagnostic Kit Exports: Export of LordsMed HIV 1&2 Self Test kits to Africa, Europe, and Latin America markets starting June 2026
- Orthosurgical Products: Sale of 153 US FDA-listed orthosurgical products to regulated international markets including US, Latin America, and Middle East
Go-to-market motion4 records
Distribution channels3 records
Marketing channels3 records
Lord's Mark product offering
Product offeringCore offering
Lord's Mark Industries Ltd. manufactures and sells AI-enabled hemodialysis machines (Lord's Renal Renalyx Machine), diagnostic self-test kits (LordsMed HIV 1&2 Self Test), and a 153-product US FDA-registered orthosurgical portfolio. The company also operates an Aureoon Dialysis-as-a-Service managed operations model that enables hospitals to run fully managed dialysis centres with zero capital investment, powered by the RenalOS AI clinical intelligence platform.
Product overview
Lord's Mark Industries operates as a diversified healthcare technology company with a platform-plus-modules architecture. The core offering centers on an integrated AI-powered renal care ecosystem comprising three interconnected components: the indigenous Lord's Renal Renalyx Machine (AI-enabled hemodialysis system), the RenalOS AI clinical intelligence platform (for monitoring and predictive analytics), and the Aureoon Dialysis-as-a-Service model (managed operations). This ecosystem is complemented by the LordsMed HIV 1&2 Self Test diagnostic product, a 153-product orthosurgical portfolio with US FDA registration, and an AI-powered breast cancer detection wearable device in development with CMET. The company positions itself at the intersection of medical devices, AI-powered healthcare technology, and indigenous manufacturing under the 'Make in India' initiative.
Differentiator
Problem solved
Functional benefit
Brands
- LordsMed: Diagnostic products brand including HIV 1&2 Self Test and other in-vitro diagnostic devices
- Lord's Renal Renalyx
- RenalOS
- Aureoon
Products and services
- Lord's Renal Renalyx Machine
- Aureoon Dialysis-as-a-Service
- LordsMed HIV 1&2 Self Test
- Orthosurgical Products Portfolio
- US FDA-Registered Healthcare Products Range
Quantifiable outcome
- Zero capital investment required from hospital partners for dialysis centre deployment
- +3 more outcomes
Companies that use Lord's Mark
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Lord's Mark technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
Lord's Mark partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- Shakti Super Speciality HospitalflagshipShakti Super Speciality Hospital in Ahmedabad serves as the first deployment site for India's first fully integrated AI-powered renal care ecosystem. The hospital hosts the Lord's Renal Renalyx Machine, RenalOS AI clinical intelligence platform, and Aureoon Dialysis-as-a-Service model.
- Centre for Materials for Electronic Technology (CMET)coreLord's Mark Industries Limited partnered with CMET to develop an AI-powered, radiation-free breast cancer detection wearable device. The device aims to improve early detection through advanced thermal sensors and AI analytics, with plans for global commercialization by the end of the year.
- Renalyx Health SystemscoreLords Mark Industries Ltd. acquired an 85% stake in Renalyx Health Systems, a Bengaluru-based med-tech company specializing in AI-enabled hemodialysis systems. The acquisition strengthens Lords Mark's healthcare technology portfolio, increases access to advanced dialysis care, and supports indigenous medical innovation under the 'Make in India' initiative.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Lord's Mark competitors and assessment
Company assessmentRegional players
- Trivitron Healthcare: Indian medical technology company manufacturing diagnostic instruments, IVD reagents, imaging equipment, and operating room devices. Closest Indian diversified medtech peer with overlapping IVD and device product lines.
- Transasia Bio-Medicals: Indian in-vitro diagnostics company with broad IVD reagents and instruments portfolio and strong domestic hospital channel. Comparable as an Indian IVD manufacturer with export ambitions overlapping LordsMed's diagnostic franchise.
- Poly Medicure: Indian medical devices company specializing in disposables and surgical consumables with growing international presence. Comparable as an Indian manufacturer scaling into regulated export markets like Lord's Mark's orthosurgical line.
Direct peers
- Nipro Corporation: Japanese medical device manufacturer with a sizeable dialysis business covering haemodialysis machines, dialyzers, and related consumables. Comparable product portfolio to Lord's Mark's Renalyx-based renal care offering.
- Fresenius Medical Care: Global leader in dialysis products and services, offering haemodialysis machines, dialyzers, and dialysis centre operations. Most directly comparable to Lord's Renal Renalyx Machine and Aureoon DaaS model in the same end market.
- DaVita: World's leading independent provider of kidney dialysis services and related lab services. Comparable to Lord's Mark on the dialysis-as-a-service and managed centre model, though DaVita is far larger and US-centric.
- B. Braun: German medical device and pharmaceutical company with a major haemodialysis equipment and services business through B. Braun Avitum. Directly competes in the same hospital dialysis equipment category as Renalyx machines.
Emerging players
- OraSure Technologies: US diagnostics company known for the OraQuick HIV self-test and other rapid point-of-care diagnostics. Most directly comparable peer in HIV self-testing, the same end market Lord's Mark targets through the LordsMed HIV 1&2 Self Test.
Broad incumbents
- Baxter International: Diversified medical products company with a legacy peritoneal dialysis franchise and broader medtech portfolio. Adjacent competitor in renal care plus comparable IVD and hospital products breadth relative to Lord's Mark's multi-line structure.
- Asahi Kasei Medical: Japanese manufacturer of dialysis membranes, therapeutic apheresis, and artificial kidneys. Comparable as an established supplier of core renal-care components consumed by dialysis programmes like the one Lord's Mark is building with Renalyx and Aureoon.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Lord's Mark compliance and trust
Trust signalCompliance6 records
Lord's Mark financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lord's Mark leadership team
Management profileNumber of profiles
Profiles1 record
Lord's Mark subsidiaries and ownership
Company hierarchySubsidiaries1 record
Lord's Mark funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lord's Mark M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lord's Mark
What does Lord's Mark do?
Lord's Mark Industries Ltd. manufactures and sells AI-enabled hemodialysis machines (Lord's Renal Renalyx Machine), diagnostic self-test kits (LordsMed HIV 1&2 Self Test), and a 153-product US FDA-registered orthosurgical portfolio. The company also operates an Aureoon Dialysis-as-a-Service managed operations model that enables hospitals to run fully managed dialysis centres with zero capital investment, powered by the RenalOS AI clinical intelligence platform.
Is Lord's Mark a public or private company?
Lord's Mark is a private company. It is classified as unknown and is currently operating.
When was Lord's Mark founded?
Lord's Mark was founded in 1998. It employs 101 to 250 people.
Where is Lord's Mark based?
Lord's Mark is headquartered in Mumbai, India, in the Asia region.
How does Lord's Mark make money?
Four revenue lines are on record. Dialysis Equipment and Consumables Sales are the primary driver. The others are dialysis-as-a-Service Managed Operations, diagnostic Kit Exports and orthosurgical Products.
Who are Lord's Mark's main competitors?
Regional players on record are Trivitron Healthcare, Transasia Bio-Medicals and Poly Medicure. Direct peers are Nipro Corporation, Fresenius Medical Care, DaVita and B. Braun. OraSure Technologies is listed as an emerging player. Broad incumbents are Baxter International and Asahi Kasei Medical.
Does Lord's Mark have an API?
No public API is recorded for Lord's Mark.
What industry is Lord's Mark in?
Lord's Mark's product category is Medical Devices. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAKAHAC, Dialysis Services (Hemodialysis & Peritoneal Dialysis). Its NAICS code is 621492 and its SIC code is 3841.